ONYX Pharmaceuticals

:

Proteolix

Dealogic Deal #  :

649523

Data as of :

10/12/2009

Target

Acquiror

Dates & Values

Proteolix

ONYX Pharmaceuticals

Target:

100

% stake

Buying:

100

% stake

Rumored

-

Deal Value $m

851.0

Unlisted

0

0

m shares outstanding

Public (Listed)

Announced

12th Oct 2009

Value ex Debt $m

851.0

United States

United States

Healthcare

Healthcare

Expected

4Q 2009

Consideration

Cooley Godward | Attorney

Completed

-

Withdrawn

-

Termination Fee, Target $m

tbd

Termination Fee, Acquiror $m

tbd

Financials

-

Balance Sheet

Debt/Equity:

-

Timeline Events

Premiums & Multiples

Initial Offer

$0.00

Current Offer

-

Income Statement

Cash Flows

Operations $m

0

Profitability

Profit Margin

-

Return on Equity

-

League Table Impact

Sector Trend

2009 YTD Announced Global M&A by Deal Value, $bn

Monthly Announced Global M&A, $bn:

Healthcare

1

Goldman Sachs

480.9

2

Morgan Stanley

473.8

3

JPMorgan

462.1

4

Citi

378.2

5

Lazard

279.3

6

BOA Merrill Lynch

275.3

7

Deutsche Bank

251.5

8

Credit Suisse

249.8

9

UBS

244.0

10

Barclays Capital

163.4

© 2009 Dealogic.  All rights reserved.